Lecture 23 and 24 - Pharm of Sex Steroids Flashcards
If estrogen drugs are given to a patient with a Uterus, it is ALWAYS given with a _______. One exception to that rule is women receiving VERY low dose Estrogen therapy for ______ atrophy –> in this case, the Estrogen can be given by itself.
Progestin
Vaginal atrophy
Remember that _______ is a protein produced by Osteoblasts that binds RANKL and blocks its interaction with RANK –> prevents Osteoclast maturation. And remember _____ (hormones) stimulates its production.
Osteoprotegerin (OPG)
Estrogen
Progesterone levels begin to rise at the beginning of the _____ phase. Keep in mind progestins halt proliferation induced by estrogens.
What happens to the endometrial lining in the absence of Progesterone?
Ovulatory
It is shed via menses.
Postmenopausal women should only receive Estrogen replacement therapy if their menopause symptoms are severe, and it should only be given for ___-___ years. The exception to that is women at high risk for developing _____ –> they can be given replacement therapy indefinitely.
1-2years
Osteoporosis
Combination oral contraceptives use an Estrogen and a Progestin, but they do not use E2 and Progesterone. Thus, they act to lower FSH, LH, Progesterone, and E2.
What effect does this have on ovulation, endometrial thickening, and formation of a cervical mucus plug?
This prevents ovulation (no LH surge or follicle maturation), renders the endometrium inappropriate for implantation (bc low progesterone), and it forms a smaller mucus plug than would otherwise be present with progesterone.
In some cases, bc it drastically lowers E2, oral contraceptives can be used to treat _______.
Endometriosis
Female horses (mares) excrete a ton of conjugated _______, and this is how they are obtained for oral contraceptives.
Conjugated Estrogens
______ _____ and ______ are the synthetic forms of Estrogen in 82 of the 83 oral contraceptive formulations in the US. On ingestion, ______ is converted to _____ _____ in the liver, so this is the active ingredient essentially in those 82 formulations –> it is a potent inducer of E2 negative feedback at the Hypothalamus.
Ethinyl Estradiol
Mestranol
Mestranol
Ethinyl Estradiol
According to the CDC, all formulations of oral contraceptives have a ____% success rate.
91%
Diethylstilbesterol is a synthetic ________ (steroidal or non-steroidal?) estrogen. How does its half-life compare to the other estrogens?
Non-steroidal –> so longer half-life.
Fluid retention is one of the moderate-severe side effects of exogenous estrogen. Estrogen increases the production of _______ in the liver –> converted to ______ –> stimulates Aldosterone –> added potential risk of HTN.
____ ____ disease, clotting disorders, myocardial infarction, and _______ are also moderate-severe risks of exogenous estrogen.
Keep in mind that risk for ______ ______ in premenopausal women is increased ONLY if they have other predisposing risk factors.
Angiotensinogen
Angiotensin II
Gall Bladder disease, Clotting disorders (Estrogen promotes production of clotting factors in liver), myocardial infarction, and Teratogenicity (if taken in the 3rd trimester)
Myocardial infarction
Unopposed Estrogens increase the risk for _______ cancer, but combination Estrogen+Progestin actually decreases this risk. The same is true for ______ cancer (including patients with BRCA1 and 2 mutations.). However, the evidence for risk of ______ cancer is inconclusive.
Endometrial cancer (this should make sense since progesterone is necessary to stop endometrial proliferation induced by estrogen)
Ovarian cancer
Breast cancer
There is increased risk for ______ adenocarcinoma in females born of mothers who took estrogens DURING the pregnancy.
Vaginal Adenocarcinoma
Estrogens also increase the risk for ____ cancer, though this is mostly attributed to HPV infection.
Cervical
Oral contraceptives are safer than pregnancy and childbirth in smokers up to about age ______, and in non-smokers up to about age ______. Thus, they would not be recommended to women of these respective ages and smoking status.
35
40